Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 4Skin Neoplasms 3Margins of Excision 2Dysplastic Nevus Syndrome 2Disease 2Carcinoma, Basal Cell 2Recurrence 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nevus 1Carcinoma, Squamous Cell 1

Interventions

Blood Specimen Collection 9Surveys and Questionnaires 6Magnetic Resonance Spectroscopy 6Dexamethasone 6Cyclophosphamide 6Prednisone 5Mammography 5Colonoscopy 5Biopsy 5Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Lenalidomide 4Biopsy, Fine-Needle 4pembrolizumab 3Tomography, X-Ray Computed 3Surgical Procedures, Operative 3Melphalan 3Liquid Biopsy 3Interviews as Topic 3Exercise 3Diagnostic Tests, Routine 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3weifuchun 2obinutuzumab 2fluciclovine F-18 2daratumumab 2carfilzomib 2Urination 2Preoperative Exercise 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Disease × Dermoscopy × Clear all
NCT04789421 2021-03-09

NET-DAM

Azienda Ospedaliero-Universitaria di Modena

Phase NA Completed
3,248 enrolled
Dermatologic

Disease, Melanoma

NCT03362138 2018-09-13

NNCD

Assuta Hospital Systems

Unknown
80 enrolled
Dermatologic

Disease, Dysplastic Nevus Syndrome, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡